Since the foundation of Syreon Middle East in 2017 our researchers have published several scientific papers, especially in the fields of health economics, health policy, health technology assessment, epidemiology and public health in prestigious scientific journals. In addition to peer-reviewed articles, our colleagues co-authored several book chapters and white papers and contributed to major international conferences.<\/p>\n\n\n\n
2026<\/strong><\/p>\n\n\n\n Mohammed Alkhaldi, Rima Kachach, Malak Alrubaie, Wissam Ghach, Sara Al Dallal, Nuriya Musina, Shadi Albarqouni, Sulafa Ahmed, Dalia Dawoud, Abeer Al-Rabayah, Mouna Jameleddine, Ahmad Nader Fasseeh, Andrea Quaiattini, Sara Ahmed – Mapping the integration of artificial intelligence and digital technologies in health technology assessment: a scoping review protocol of global knowledge and practices<\/strong><\/a><\/p>\n\n\n\n 2025<\/strong><\/p>\n\n\n\n Mosli, Mahmoud H., Almutairdi, Abdulelah A., Alshahrani, Abdullah M., Alkhurmi, Abdulrahman M., Fasseeh, Ahmad N., Anwar, Ali M., Alharbi, Bandar M., Altawil, Esraa S., Alshareef, Haneen J., Alqasim, Hussain A., Alharbi, Ibtisam H., El-Fass, Kareem A., Alanizy, Layla N., Almehizia, Rayd A., Hren, Rok, Iskandarani, Wael K., Alabdulkarim, Hana A. – Cost calculation model of introducing Upadacitinib and Risankizumab for adult ulcerative colitis and Crohn\u2019s disease in the Kingdom of Saudi Arabia<\/strong><\/a><\/p>\n\n\n\n Baher Elezbawy, Nada Abaza, Mirna Fasseeh, Rawda Elshahawy, Yosra S. Mahmoud, Hassan Hendawy, Sergey R. Konstantinov, Javier Ruiz-Gui\u00f1az\u00fa, Corinne Willame, Jeroen Geurtsen, Janssen Vaccines and Prevention B.V., Leiden, The Netherlands, Jan Poolman, Zolt\u00e1n Voko, D\u00e1vid Nagy, Tam\u00e1s Zelei, S\u00e1ndor Kov\u00e1cs, Szimonetta Lohner – Incidence of staphylococcus aureus infections after surgical interventions: a systematic review and meta-analysis<\/strong><\/a><\/p>\n\n\n\n Sara Al dallal, Sinan Ghazi, Firas Jabbar, Mohamed Farghaly, Ahmad Nader Fasseeh, Nada Korra, Ahmed Shalaby, Youssef H. Ahmed, Mashhour Arraj, Sameh Elgouhari, Sherif Abdelsamie, Waleed Fahim, Zaid Hamandi, Mohamed Tahoun, Sherif Abaza, G\u00e1bor Kov\u00e1cs – Cost-effectiveness analysis of seasonal influenza vaccination compared to no vaccination in the United Arab Emirates and Iraq<\/strong><\/a><\/p>\n\n\n\n Ahmad Nader Fasseeh, Rasha Ashmawy, Rok Hren, Kareem ElFass, Attila Imre, Bertalan N\u00e9meth, D\u00e1vid Nagy, Bal\u00e1zs Nagy, Zolt\u00e1n Vok\u00f3 – Generating Realistic Synthetic Patient Cohorts: Enforcing Statistical Distributions, Correlations, and Logical Constraints<\/strong> https:\/\/www.mdpi.com\/1999-4893\/18\/8\/475<\/strong><\/a><\/p>\n\n\n\n Ahmad Nader Fasseeh, Amany Ahmed Salem, Ahmed Yehia Khalifa, Asmaa Khairy ElBerri, Nada Abaza, Baher Elezbawy, Naeema Al Qasseer, Bal\u00e1zs Nagy, Zolt\u00e1n Kal\u00f3, Bertalan N\u00e9meth, Rok Hren – Cost Utility Modeling of Reducing Waiting Times for Elective Surgical Interventions: Case Study of Egyptian Initiative<\/strong> https:\/\/www.mdpi.com\/2227-9032\/13\/13\/1619<\/strong><\/a><\/p>\n\n\n\n Ahmad Jazzar, Kaiser Raja , Omar N. Fasseeh, Ahmed Rasmy, Ahmed Gomaa, Naglaa Nasr, Ahmad N. Fasseeh – Cost-Effectiveness of S-Adenosyl-L-Methionine for Intrahepatic Cholestasis in the United Arab Emirates https:\/\/www.cureus.com\/articles\/337893-cost-effectiveness-of-s-adenosyl-l-methionine-for-intrahepatic-cholestasis-in-the-united-arab-emirates#!\/<\/a><\/strong><\/p>\n\n\n\n Bardia Talebzadeh, Arash Ghazbani, Ahmad Nader Fasseeh, Sanaz Zargar Balaye Jame, Seyyed Ziya Hejrypour, Kimia Karami, Faezeh Sarooeyeh, Masoud Behzadifar, Zolt\u00e1n Kal\u00f3 – Implementation roadmap of Health Technology Assessment in Iran<\/strong> https:\/\/doi.org\/10.1016\/j.hlpt.2025.101015<\/strong><\/a><\/p>\n\n\n\n Rawda Elshahawy, Baher Elezbawy, Rasha Ashmawy, Rowan Elshahawy, Yosra S. Mahmoud, Nada Korra, Sherif Abaza, Amal Alnajjar, Hana A. Al-Abdulkarim, Hussain A. Al-Omar, Sahar Fahmy, Sara Al Dallal, Ahmad N. Fasseeh – Global Economic Burden of Spinal Muscular Atrophy: A Systematic Literature Review<\/strong> doi:10.7759\/cureus.81023<\/strong><\/strong><\/a><\/p>\n\n\n\n Ahmad Nader Fasseeh, Nada Korra, Ahmed Aljedai, Ahmed Seyam, Hajer Almudaiheem, Hana A. Al-Abdulkarim, Marwan Janahi, Mary Gamal, Sahar Fahmy, Sara Aldallal, Sherif Abaza, Zolt\u00e1n Kal\u00f3 – Rare disease challenges and potential actions in the Middle East<\/strong> https:\/\/equityhealthj.biomedcentral.com\/articles\/10.1186\/s12939-025-02388-4<\/strong><\/a><\/p>\n\n\n\n Baher Elezbawy, Zolt\u00e1n Kal\u00f3, Ahmad Fasseeh, Andr\u00e1s Inotai, Bertalan Nemeth, Tam\u00e1s \u00c1gh – The hidden burden of atopic dermatitis in central and Eastern European countries<\/strong> https:\/\/doi.org\/10.1080\/14737167.2024.2416249<\/strong><\/a><\/p>\n\n\n\n Rok Hren, Nada Abaza, Baher Elezbawy, Ahmed Khalifa, Ahmad N. Fasseeh, Naeema Al Gasseer, Zolt\u00e1n Kal\u00f3 – Economic Benefits of Reduced Waiting Times for Elective Surgeries: A Systematic Literature Review<\/strong> doi:10.7759\/cureus.79417<\/a><\/strong><\/strong><\/p>\n\n\n\n Ahmad N Fasseeh, Emad Almomani, Baher Elezbawy, Youssef H Ahmed, Kareem A El-Fass, Emad Alsharu, Zolt\u00e1n Kal\u00f3 – A Financial Benefit-Cost Analysis of Advancing Jordan’s Medical Tourism: The Case of Proton Therapy<\/strong> https:\/\/doi.org\/10.7759\/cureus.77119<\/strong><\/a><\/p>\n\n\n\n 2024<\/strong><\/p>\n\n\n\n Bal\u00e1zs Nagy, Ahmad Nader Fasseeh , Jonathan D. Campbell , Zolt\u00e1n Kal\u00f3 , Kareem Ahmed El-Fass , Rok Hren , Bertalan N\u00e9meth – Tradeoffs When Building and Running Cohort and Patient-Level Markov Simulation Models<\/strong> https:\/\/doi.org\/10.3390\/a17120546<\/strong><\/a><\/p>\n\n\n\n Mohamed Farghaly , Kareem A. El-Fass , Nabil Amin , Shazia Qaiser , Mona Attallah , Qasim Farooq , Mohamed Badr , Sara Al Dallal , Mona Farah , Rahul Nathwani , Atheer Alansari , Ahmad Jazzar , Ashraf Reda , Martin Lee , Ahmed Abogamal , Ahmad N. Fasseeh , Zolt\u00e1n Kal\u00f3 – Regulatory Framework for Supporting the Integration and Use of Biosimilars in the Private Healthcare System of the United Arab Emirates (UAE)<\/strong> https:\/\/doi.org\/10.7759\/cureus.77119<\/strong><\/a><\/p>\n\n\n\n Sara Aldallal, Mohamed Farghaly, Sahar Fahmy, Khalid A Alnaqbi, Wael Al Naeem, Mouza Alsaadi, Marleine Moukarzel, Ahmad Nader Fasseeh, Nada Korra, Sherif Abaza, Zolt\u00e1n Kal\u00f3 – Thresholds for the value judgement of health technologies in the United Arab Emirates: a consensus approach through voting sessions<\/strong> https:\/\/doi.org\/10.1136\/bmjopen-2024-090344<\/strong><\/a><\/p>\n\n\n\n Baher Elezbawy, Zolt\u00e1n Kal\u00f3, Ahmad Fasseeh, Andr\u00e1s Inotai, Bertalan Nemeth, Tam\u00e1s \u00c1gh – The hidden burden of atopic dermatitis in central and Eastern European countries<\/strong><\/strong> https:\/\/www.tandfonline.com\/doi\/abs\/10.1080\/14737167.2024.2416249<\/strong><\/a><\/p>\n\n\n\n Ibrahim Alrashdi, Sara albalushi, Alia Al Shuaili, Said wani, Nadiya AlBulushi Gla AlBulushi, Asiya Ibrahim Al Kindi, Qasem Al Salmi, Hilal Alsabti, Nada Korra, Sherif Abaza, Ahmad Fasseeh, Zolt\u00e1n Kal\u00f3 – A roadmap towards implementing health technology assessment in Oman<\/strong> https:\/\/doi.org\/10.1108\/JHOM-01-2024-0012<\/strong><\/a><\/p>\n\n\n\n Ahmad N. Fasseeh, Nada Korra, Baher Elezbawy, Amal S. Sedrak, Mary Gamal, Randa Eldessouki, Mariam Eldebeiky, Mohsen George, Ahmed Seyam, Asmaa Abourawash, Ahmed Y. Khalifa, Mayada Shaheen, Sherif Abaza & Zolt\u00e1n Kal\u00f3 – Framework for developing cost-effectiveness analysis threshold: the case of Egypt<\/strong>. https:\/\/doi.org\/10.1186\/s42506-024-00159-7<\/strong><\/a><\/p>\n\n\n\n Khalid A. Alnaqbi, MBBS, MSc, Amin Mohamed Elshamy, PhD, Nicole Gebran, PharmD, Sahar Fahmy, PhD, Sara Aldallal, MSc, Nada Korra, PharmD, Ahmad Nader Fasseeh, PhD, Zolt\u00e1n Kal\u00f3, PhD – Consensus-Based Recommendations for the Implementation of Health Technology Assessment in the United Arab Emirates<\/strong> https:\/\/doi.org\/10.1016\/j.vhri.2024.101012<\/strong><\/a><\/p>\n\n\n\n Khalid A. Alnaqbi, Baher Elezbawy, Ahmad N. Fasseeh, Abdul Rauf Bangash, Amin Elshamy, Hiba Shendi, Mohammed I. Aftab, Mozah AlMarshoodi , Nicole Gebran, Noura AlDhaheri, Sahar A. Fahmy, Sara Al Dallal, Waeil Al Naeem, Sherif Abaza, Zolt\u00e1n Kal\u00f3 – Development of the Emirates Multi-Criteria Decision Analysis Tool for Orphan Drugs<\/strong> DOI: 10.7759\/cureus.55215<\/strong><\/a><\/p>\n\n\n\n Baher Elezbawy, MPH , Mohamed Farghaly, PhD, Atlal Al Lafi, PhD, Mary Gamal, MSc, Mirna Metni, PharmD, Willem Visser, PhD, Hana Al-Abdulkarim, MSc, Meriem Hedibel, PharmD, Ahmad Nader Fasseeh, PhD, Sherif Abaza, MBA, Zolt\u00e1n Kal\u00f3, PhD – Strategic Approaches to Reducing the Burden of Atopic Dermatitis in the Middle East and Africa Region<\/strong> https:\/\/doi.org\/10.1016\/j.vhri.2024.100987<\/strong><\/a><\/p>\n\n\n\n 2023<\/strong><\/p>\n\n\n\n Ahmad Nader Fasseeh, Baher Elezbawy, Kareem Ahmed El-Fass, Mary GamaI, Ahmed Seyam, Noha Hayek, Nagwan Abdel Rahman, Sohir Abdelhamid, Nader Fasseeh, Amr Shafik Saad, Ahmed Elagamy, Akram Mahmoud, Amal Samir Sedrak, Khaled Elshazly, Mariam Eldebeiky, Monica Talaat, Noura Maher Mohamed, Rania Ahmed Abdelaziz, Remonda Refaat, Shaimaa Akeel, Sherif Abaza & Zolt\u00e1n Kal\u00f3 – Maximizing the benefits of using biosimilars in Egypt<\/strong>. https:\/\/doi.org\/10.1186\/s40545-023-00581-w<\/strong><\/a><\/p>\n\n\n\n Ahmad Fasseeh; Amany Ahmed Salem ; Ahmed M. Rasmy; Hanaa El Gendy; Laszlo Szilberhorn; Tarek Barakat; Mahmoud Radwan; Balaz Nagy – Cost-Effectiveness Analysis of Ceftazidime\/Avibactam Versus Polymyxin E in The Treatment of Carbapenem-Resistant Enterobacteriaceae Infections: Literature Review<\/strong>. doi:https:\/\/dx.doi.org\/10.21608\/ejhm.2023.287325<\/strong><\/a><\/p>\n\n\n\n Baher Elezbawy, Ahmad Nader Fasseeh, Essam Fouly, Mohamed Tannira, Hala Dalle, Sandrine Aderian, Laila Carolina Abu Esba, Hana Al Abdulkarim, Alfred Ammoury, Esraa Altawil, Abdulrahman Al Turaiki, Fatima Albreiki, Mohammed Al-Haddab.Atlal Al-Lafi, Maryam Alowayesh, Afaf Al-Sheikh, Mahira Elsayed, Amin Elshamy, Maysa Eshmawi, Assem Farag, Issam Hamadah, Meriem Hedibel, Suretha Kannenberg, Rita Karam, Mirna Metni, Noufal Raboobee, Martin Steinhoff, Sherif Abaza, Mohamed Farghaly, Zoltan Kalo \u0301 – Humanistic and Economic Burden of AtopicDermatitis for Adults and Adolescents in the MiddleEast and Africa Region<\/strong>. https:\/\/doi.org\/10.1007\/s13555-022-00857-0<\/strong><\/a><\/p>\n\n\n\n 2022<\/strong><\/p>\n\n\n\n Ahmad Nader Fasseeh, Baher Elezbawy, Mary Gamal,Ahmed Seyam, Asmaa Abourawash, Mohsen George,Mohamed Anwar,Magdy Amin,Ahmed Yehia Khalifa,Amr Elshalakani, Ashraf Hatem, Sohir Abdelhamid,Hossam Elsamouly, Nader Fasseeh, Randa Adel,Hatem Dawood, Sherif Abaza and Zolt\u00e1n Kal\u00f3 – A roadmap toward implementing health technology assessment in Egypt.<\/strong> doi:10.3389\/fpubh.2022.896175<\/a><\/p>\n\n\n\n Baher Elezbawy, Ahmad Nader Fasseeh, Bertalan N\u00e9meth, Mary Gamal, Mariam Eldebeiky, Remonda Refaat, Amr Taha, Shimaa Rabiea, Marwa Abdallah, Soha Ramadan, Hasnaa Noaman, Amany Bahaa Eldin, Hossam Mostafa, Sara Nouh, Asmaa Zaki, Mohamed Abdelrahman, Sherif Abaza & Zolt\u00e0n Kal\u00f2 – A multicriteria decision analysis (MCDA) tool to purchase implantable medical devices in Egypt<\/strong>.https:\/\/doi.org\/10.1186\/s12911-022-02025-y<\/a><\/p>\n\n\n\n Baher Elezbawy, Ahmad Nader Fasseeh, Essam Fouly, Laila Carolina Abu Esbac,Hana Al Abdulkarim, Mohammed Al-Haddabd, Afaf Al-Sheikh, Esraa Altawil, Abdulrahman Al Turaiki,Maysa Eshmawi, Issam Hamadah, Mohamed Tannira, Hala Dalle, Sandrine Aderian, Ahmed Roshdy, Ahmed Jaheen, Tharwat Hamad, Sherif Abaza and Zoltan Kalo – The humanistic and economic burden of atopic dermatitis among adults and adolescents in Saudi Arabia<\/strong>. https:\/\/doi.org\/10.1080\/13696998.2022.2152234<\/a><\/p>\n\n\n\n Ahmad N. Fasseeh, Baher Elezbawy, Nada Korra, Mohamed Tannira, Hala Dalle, Sandrine Aderian, Sherif Abaza, Zoltan Kalo \u0301 – Burden of Atopic Dermatitis in Adultsand Adolescents: a Systematic Literature Review<\/strong>. doi:10.1007\/s13555-022-00819-6<\/a><\/p>\n\n\n\n Baher Elezbawy, Ahmad Nader Fasseeh, Amal Sedrak, Randa Eldessouki, Mary Gamal, Mariam Eldebeiky, Hanaa Amer, Shimaa Akeel, Ahmad Morsy, Amira Amin, Amr Shafik, Sherif Abaza & Zolt\u00e1n Kal\u00f3 – A multi-criteria decision analysis (MCDA) tool for purchasing off-patent oncology medicines in Egypt<\/strong>. doi:10.1186\/s40545-022-00414-2<\/a><\/p>\n\n\n\n Ahmad Nader Fasseeh, Sarah Maria Saragih, Noha Hayek, Sasha Brodovska ,Adham Ismail , Amr ElShalakani , Sherif Abaza , George Dennis Obeng , David Ameyaw ,Zoltan Kalo – Impact of health technology assessment implementation with a special focus on middle-income countries<\/strong>. doi:10.1016\/j.hlpt.2022.100688<\/a><\/p>\n\n\n\n Ahmad Fasseeh, Baher ElEzbawy, Wessam Adly, Rawda ElShahawy, Mohsen George, Sherif Abaza, Amr ElShalakani & Zolt\u00e1n Kal\u00f3 – Healthcare financing in Egypt: a systematicliterature review<\/strong>. doi:10.1186\/s42506-021-00089-8<\/a><\/p>\n\n\n\n Mohamed Aboulghate, Aliaa Elaghoury, Ibrahim Elebrashy, Nabil Elkafrawy, Galal Elshishiney, Ehab Abul-Magd, Engy Bassiouny, Dalia Toaima, Baher Elezbawy, Ahmad Fasseeh, Sherif Abaza and Zolt\u00e1n Vok\u00f3 – The Burden of Obesity in Egypt<\/strong>. doi:\/10.3389\/fpubh.2021.718978<\/a><\/p>\n\n\n\n 2018<\/strong><\/p>\n\n\n\n A Fasseeh, B N\u00e9meth, A Moln\u00e1r, F-U Fricke, M Horv\u00e1th, K K\u00f3czi\u00e1n, \u00c1 G\u00f6tze, Z Kal\u00f3 – A systematic review of the indirect costs of schizophrenia in Europe<\/strong>. doi.org\/10.1093\/eurpub\/cky231<\/a><\/p>\n\n\n\n Bertalan N\u00e9meth, Ahmad Fasseeh, Anett Moln\u00e1r, Istv\u00e1n Bitter, Margit Horv\u00e1th, Krist\u00f3f K\u00f3czi\u00e1n, \u00c1rp\u00e1d G\u00f6tze & Bal\u00e1zs Nagy – A systematic review of health economic models and utility estimation methods in schizophrenia<\/strong>. doi:\/10.1080\/14737167.2018.1430571<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" Since the foundation of Syreon Middle East in 2017 our researchers have published several scientific papers, especially in the fields of health economics, health policy, health technology assessment, epidemiology and public health in prestigious scientific journals. In addition to peer-reviewed articles, our colleagues co-authored several book chapters and white papers and contributed to major international… Read More »SCIENTIFIC PUBLICATIONS<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","_themeisle_gutenberg_block_has_review":false,"_ti_tpc_template_sync":false,"_ti_tpc_template_id":"","footnotes":""},"class_list":["post-388","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/syreon.me\/index.php\/wp-json\/wp\/v2\/pages\/388","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/syreon.me\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/syreon.me\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/syreon.me\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/syreon.me\/index.php\/wp-json\/wp\/v2\/comments?post=388"}],"version-history":[{"count":46,"href":"https:\/\/syreon.me\/index.php\/wp-json\/wp\/v2\/pages\/388\/revisions"}],"predecessor-version":[{"id":912,"href":"https:\/\/syreon.me\/index.php\/wp-json\/wp\/v2\/pages\/388\/revisions\/912"}],"wp:attachment":[{"href":"https:\/\/syreon.me\/index.php\/wp-json\/wp\/v2\/media?parent=388"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
Ahmad N. Fasseeh, Emad Almomani, Baher Elezbawy, Youssef H. Ahmed, Kareem A. El-Fass, Emad Alsharu, Zolt\u00e1n Kal\u00f3 – A Financial Benefit-Cost Analysis of Advancing Jordan’s Medical Tourism: The Case of Proton Therapy<\/strong> https:\/\/doi.org\/10.7759\/cureus.77119<\/strong><\/a><\/p>\n\n\n\n